MARCHF8 and Zika virus infectious disease: Our data showing that MARCH8 is also required for DENV and ZIKV infections, suggest that MARCH8 may represent a target for broader-spectrum antivirals, similar to cellular kinases (Bekerman and Einav, 2015; Bekerman et al., 2017).